The Overexpression of Suppresses the Ovarian Cancer Progression the Inhibition of Integrin β1/AKT Signaling Pathway.

Ovarian cancer is considered as one of the most fatal gynecologic malignancies. This work aimed to explore the effects and regulatory mechanism of (, a subunit of CoA ligases) in ovarian cancer progression. As well as employing CCK-8 assay, clone formation assay, and cell cycle analysis were carried out to investigate cell proliferation ability. Wound healing assay and transwell assay were subsequently used to assess cell migration and invasion. Mice xenografts were then conducted to measure the effects of on tumor development . Our bioinformatics analysis suggested that the expression of was down-regulated in ovarian cancer tissues, and the low expression level of might related with poorer overall survival than high mRNA expression of in ovarian cancer patients. We artificially regulated the expression of to evaluate its effects on ovarian cancer malignant phenotypes. Our data revealed that the overexpression of inhibited cell proliferation, migration, and invasion of ovarian cancer cells. In contrast, the knock-down of received the opposite results. Our western blot results showed that the Integrin β1/AKT signaling pathway was negatively regulated by expression. Moreover, overexpression-induced suppression of cell migration and invasion activities were abolished by the overexpression of (Integrin β1). Additionally, the growth of ovarian cancer xenograft tumors was also repressed by the overexpression of . And interference obtained the contrary effects . In summary, acts as a tumor suppressor gene and may be a potential therapeutic target of ovarian cancer.